Search Results

There are 8354 results for: content related to: Association of IL 28B polymorphisms with peginterferon treatment response in Chinese Han patients with HB eAg-positive chronic hepatitis B

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 127–132, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12404

  3. You have free access to this content
    Viral Hepatitis

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 151–177,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_14

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. You have free access to this content
    The importance of IL28B genotype in hepatitis C virus-associated liver transplantation

    Liver International

    Volume 33, Issue 2, February 2013, Pages: 169–171, Christian M. Lange

    Version of Record online : 7 JAN 2013, DOI: 10.1111/liv.12071

  6. You have free access to this content
    IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 74–78, Donald M. Jensen and Stanislas Pol

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02712.x

  7. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Version of Record online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  8. You have free access to this content
    HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 112–119, Jia-Horng Kao

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12400

  9. You have free access to this content
    Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 20–29, Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, Keisuke Tanaka, Yuichiro Suzuki, Nobuharu Tamaki, Yoshihide Hoshioka, Yutaka Yasui, Tomoji Katoh, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Sayuri Nitta, Naoya Sakamoto and Namiki Izumi

    Version of Record online : 29 NOV 2011, DOI: 10.1002/hep.24623

  10. Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders

    Liver International

    Volume 35, Issue 10, October 2015, Pages: 2275–2284, Balazs Fülöp, Michael Biermer, Markus Cornberg, Heiner Wedemeyer, Kerstin Port, Renate Heyne, Stefan Zeuzem, Kai-Henrik Peiffer, Tania Welzel, Adam Herber, Peter Buggisch, Christoph Moser, Sabine Stoll, Ulrich Alshuth and Thomas Berg

    Version of Record online : 20 APR 2015, DOI: 10.1111/liv.12832

  11. Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients

    Hepatology Research

    Volume 44, Issue 9, September 2014, Pages: 1000–1007, Lin Cheng, Xiaowen Sun, Shun Tan, Wenting Tan, Yunjie Dan, Yi Zhou, Qing Mao and Guohong Deng

    Version of Record online : 9 JAN 2014, DOI: 10.1111/hepr.12284

  12. You have free access to this content
    Abstracts 1–199

    Hepatology

    Volume 52, Issue S1, October 2010, Pages: 320A–421A,

    Version of Record online : 30 SEP 2010, DOI: 10.1002/hep.23974

  13. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26726

  14. You have free access to this content
    Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 2, July 2012, Pages: 91–103, Y. Chen, H.-X. Xu, L.-J. Wang, X.-X. Liu, R. I. Mahato and Y.-R. Zhao

    Version of Record online : 16 MAY 2012, DOI: 10.1111/j.1365-2036.2012.05131.x

  15. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Version of Record online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  16. You have free access to this content
    Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 157–163, Pietro Lampertico, Mauro Viganò and Massimo Colombo

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12064

  17. Basic Science Luminal

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue s4, October 2012, Pages: 17–29,

    Version of Record online : 11 SEP 2012, DOI: 10.1111/j.1440-1746.2011.07251_2.x

  18. You have free access to this content
    Hepatitis C pharmacogenetics: State of the art in 2010

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 336–345, Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean-Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein and for the Pharmacogenetics and Hepatitis C Meeting Participants

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.24052

  19. Nutrition Clinical

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue s4, October 2012, Pages: 140–149,

    Version of Record online : 11 SEP 2012, DOI: 10.1111/j.1440-1746.2011.07251_9.x

  20. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 846–853, Senem C. Karataylı, Mithat Bozdayı, Ersin Karataylı, Tuğba Öztürk, Abbas A. Husseini, Rabia Albayrak, Muhip Özkan, Zeynep Kalaylıoğlu, Kendal Yalçın, Kubilay Çınar, Ramazan İdilman and Cihan Yurdaydın

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12595